Methyl Indole-4-Carboxylate CAS 39830-66-5 Purity >98.0% (HPLC) Factory High Quality Featured Image

Methyl Indole-4-Carboxylate CAS 39830-66-5 Purity >98.0% (HPLC) wheketere Kounga teitei

Whakaahuatanga Poto:

Ingoa matū: Methyl Indole-4-Carboxylate

CAS: 39830-66-5

Maamaa: >98.0% (HPLC)

Kowhai Maama ki te Maama Whero-whero-whero Kowhai Karaihe Paura ranei

Kounga Teitei, Hanganga Aromoni

E-Mail: alvin@ruifuchem.com

Tukuna he imeera ki a matou

Taipitopito Hua

Hua e Pa ana

Tohu Hua

Whakaahuatanga:

Ko Shanghai Ruifu Chemical Co., Ltd. te kaihanga matua me te kaiwhakarato o Methyl Indole-4-Carboxylate (CAS: 39830-66-5) me te kounga teitei, te hanga arumoni.Nau mai ki te ota.

Nga Ahuatanga matū:

Ingoa matū	Methyl Indole-4-Carboxylate
Nga kupu taurite	Methyl 4-Indolecarboxylate;Indole-4-Carboxylic Acid Methyl Ester
Tau CAS	39830-66-5
Tau CAT	RF-PI1555
Tūnga Taonga	I roto i te Stock, Production Tauine Up ki Taranata
Tātai rāpoi	C10H9NO2
Taumaha rāpoi	175.19
Wairewa	Wairewa ki Methanol
Waitohu	Ruifu Chemical

Whakatakotoranga:

Tūemi	Whakatakotoranga
Te ahua	Kowhai Maama ki te Maama Whero-whero-whero Kowhai Karaihe Paura ranei
1 H NMR Spectrum	E rite ana ki te Hanganga
Te Maama / Tikanga Tatauria	>98.0% (HPLC)
Te Whakarewa	68.0~71.0℃ (marama)
Ngaronga i te whakamaroke	<1.00%
Te toenga i runga i te mura	<0.20%
Nga poke katoa	<2.00%
Paerewa Whakamatau	Paerewa hinonga
Whakamahinga	Takawaenga Rongoa

Mōkī me te Rokiroki:

Mōkī: Pounamu, Peeke konumohe konumohe, 25kg / Cardboard Drum, kia rite ranei ki te hiahia a te kaihoko.

Tikanga Rokiroki:Whakaorangia i roto i nga ipu kua hiri ki te waahi makariri me te maroke;Tiaki i te marama me te makuku.

Painga:

FAQ:

Taupānga:

Methyl Indole-4-Carboxylate (CAS: 39830-66-5),Tauhohenga mo te whakarite i nga aukati tryptophan dioxygenase pyridyl-ethenyl-indoles hei immunomodulators anticancer pea;Tauhohenga mo te whakareri i nga matū cytotoxic ki nga pūtau mate pukupuku multidrug-resistant;Reactant mo te whakarite i te aukati mo te β-tryptase;Reactant mo te whakarite i nga antagonists H3 histamine;Reactant mo te whakarite o JNK3 MAP kinase inhibitors;Tauhohenga mo te whakareri nucleoside.